Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
58
58 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- NSC001Phase 21 trial
NSC-Therapeutics · Alzheimer Disease
- NTRX-07MDA7Phase 21 trial
NeuroTherapia, Inc. · Alzheimer Disease, Mild Cognitive Impairment
- PRI-002ContraloidPhase 21 trial
PRInnovation GmbH · Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease, Early Onset
- RO7269162Phase 21 trial
Roche (Genentech) · Alzheimer's Disease
- sabirnetugPhase 21 trial
Acumen Pharmaceuticals · Alzheimer Disease
- SAR448851Phase 21 trial
Sanofi · Dementia, Alzheimer's Type, Alzheimer's Disease
- VY7523Phase 21 trial
Voyager Therapeutics · Alzheimer's Disease (AD)
- XPro1595INB03, XProPhase 21 trial
Inmune Bio, Inc. · Alzheimer Disease, Dementia, Brain Diseases
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.